Position in LYEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,454,791
-$129,517 QoQ
Shares Held
72,522
+40.9% QoQ
Ownership
0.311%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 67%
Shared 0%
None 33%
Common Shares in LYEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,288,856,014 across 423 Biotechnology names. LYEL ranks #250 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in LYEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,454,791 | 72,522 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,584,308 | 51,472 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $548,132 | 33,752 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $299,207 | 33,847 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||